Table 1.
Bafilomycin | Bafilomycin added to aqueous side
|
Bafilomycin added to blood side
|
||
---|---|---|---|---|
SCC, μA | PD, mV | SCC, μA | PD, mV | |
None | −8.1 ± 0.8 | 0.55 | −8.5 ± 0.6 | 0.45 |
1 nM | −7.7 ± 1.3 | 0.55 | −8.5 ± 0.8 | 0.45 |
10 nM | −7.8 ± 0 | 0.55 | −8.5 ± 0.6 | 0.45 |
100 nM | −7.7 ± 0.8 | 0.55 | −8.5 ± 0.6 | 0.45 |
1 μM | −6.0 ± 0.9* | 0.40 | −10.4 ± 0.6 | 0.45 |
10 μM | −4.2 ± 0.9** | 0.40 | −12.4 ± 0.9* | 0.40 |
Bafilomycin was added to the bath in increasing concentrations every 30 min and transepithelial measurements (26) were obtained. ∗, P < 0.05; ∗∗, P < 0.01.